Fingerprint
Dive into the research topics of 'AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes
L. Katz, N. Manamley, W. J. Snyder, M. Dodds, N. Agafonova, J. Sierra-Johnson, M. Cruz, P. Kaur, S. Mudaliar, Philip Raskin, R. Kewalramani, A. Pellacani
Research output: Contribution to journal › Letter › peer-review
41
Scopus
citations